Advertisement
Upstream Bio Inc. (UPB)
Upstream Bio Statistics
Share Statistics
Upstream Bio has 53.69M shares outstanding. The number of shares has increased by null% in one year.
Shares Outstanding | 53.69M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Institutions (%) | n/a |
Shares Floating | - |
Failed to Deliver (FTD) Shares | 1.51K |
FTD / Avg. Volume | 0.57% |
Short Selling Information
Short Interest | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is null. Upstream Bio's PEG ratio is 0.
PE Ratio | 0 |
Forward PE | n/a |
PS Ratio | 0 |
Forward PS | n/a |
PB Ratio | 0 |
P/FCF Ratio | 0 |
PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Upstream Bio.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 44.63, with a Debt / Equity ratio of 0.
Current Ratio | 44.63 |
Quick Ratio | 44.63 |
Debt / Equity | 0 |
Debt / EBITDA | -0.02 |
Debt / FCF | -0.03 |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $45.58K |
Profits Per Employee | $-1.21M |
Employee Count | 52 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 0.49, so Upstream Bio's price volatility has been higher than the market average.
Beta | 0.49 |
52-Week Price Change | null% |
50-Day Moving Average | 7.93 |
200-Day Moving Average | null |
Relative Strength Index (RSI) | 55.53 |
Average Volume (20 Days) | 266.92K |
Income Statement
In the last 12 months, Upstream Bio had revenue of 2.37M and earned -62.81M in profits. Earnings per share was 0.
Revenue | 2.37M |
Gross Profit | 2.37M |
Operating Income | -77.76M |
Net Income | -62.81M |
EBITDA | -77.67M |
EBIT | -77.76M |
Earnings Per Share (EPS) | 0 |
Balance Sheet
The company has 325.89M in cash and 1.83M in debt, giving a net cash position of 324.06M.
Cash & Cash Equivalents | 325.89M |
Total Debt | 1.83M |
Net Cash | 324.06M |
Retained Earnings | -190.78M |
Total Assets | - |
Working Capital | - |
Cash Flow
In the last 12 months, operating cash flow was -59.17M and capital expenditures -511K, giving a free cash flow of -59.68M.
Operating Cash Flow | -59.17M |
Capital Expenditures | -511K |
Free Cash Flow | -59.68M |
FCF Per Share | 0 |
Margins
Gross margin is 100%, with operating and profit margins of -3281.18% and -2650.04%.
Gross Margin | 100% |
Operating Margin | -3281.18% |
Pretax Margin | -2650.04% |
Profit Margin | -2650.04% |
EBITDA Margin | -3277.43% |
EBIT Margin | -3281.18% |
FCF Margin | -2518.27% |
Dividends & Yields
UPB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for UPB is $56.5, which is 537.7% higher than the current price. The consensus rating is "Buy".
Price Target | $56.5 |
Price Target Difference | 537.7% |
Analyst Consensus | Buy |
Analyst Count | 4 |
Scores
Altman Z-Score | null |
Piotroski F-Score | null |